A total of 114 serum specimens from 76 blood donors, 21 patients with acquired immune deficiency syndrome or acquired immune deficiency syndrome-related complex, 7 multiply transfused patients, 3 hemophiliacs, and 7 others were tested for anti-human immunodeficiency virus type 1 (HIV-1) antibody by enzyme immunoassay (EIA) and Western blot (WB) and then blindly tested by immunofluorescence (IF) (11, 13, 16, 27, 33, 34) , time-resolved fluoroimmunoassay (1), radioimmunoprecipitation (26), immunoperoxidase slide test (14) , neutralization test (18, 20, 22, 23) , latex agglutination (19, 21), and passive particle agglutination (PPA) (35). Although second-generation EIAs have better performance characteristics (sensitivity and specificity) than earlier screening tests, the continuing problem of false-positive results necessitates the use of a highly specific confirmatory test. WB has been a very useful test for detecting EIA false-positive sera, but it is not without serious disadvantages, including a specificity problem (2, 3, 5, 6, 9, 17, 24, 25) MATERIALS AND METHODS Sera. Sera were collected from various populations in Hamilton, Ontario, Canada, including blood donors (tested by the Hamilton Centre of the Canadian Red Cross Blood Transfusion Service during 1986); acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) patients, as defined by the case definition criteria of the Centers for Disease Control (7); hemophiliacs; multiply transfused patients; and seven others who were undergoing other viral serology testing. Blood donor sera which were positive by a screening EIA without repeat testing or WB confirmation were selected for the IF observer agreement study. One set of 20 repeat serum specimens selected part way through the study and consisting of 15 IF assay-WB positives and 5 IF assay-WB negatives was included with the sera to provide a sample with approximately 50% positivity for the interlaboratory observer agreement study.
Serologic screening for antibody to human immunodeficiency virus type 1 (HIV-1) has been a major responsibility of blood banks and more recently of transplantation centers in order to ensure that HIV-1 infection is not transmitted iatrogenically. Antibody to HIV has been detected by various assays, including enzyme immunoassay (EIA) with whole virus antigen (4, 28) or recombinant antigens (15, 29) , Western blot (WB) (30, 32) , indirect immunofluorescence (IF) (11, 13, 16, 27, 33, 34) , time-resolved fluoroimmunoassay (1) , radioimmunoprecipitation (26) , immunoperoxidase slide test (14) , neutralization test (18, 20, 22, 23) , latex agglutination (19, 21) , and passive particle agglutination (PPA) (35) . Although second-generation EIAs have better performance characteristics (sensitivity and specificity) than earlier screening tests, the continuing problem of false-positive results necessitates the use of a highly specific confirmatory test. WB has been a very useful test for detecting EIA false-positive sera, but it is not without serious disadvantages, including a specificity problem (2, 3, 5, 6, 9, 17, 24, 25) (13) . Both laboratories were cognizant of the occurrence of antilymphocyte antibodies in sera, but no specific discussion of criteria and no observer training regarding antilymphocyte staining took place. During the 5-week period of testing, seven groups of coded serum specimens were transported between laboratories and tested blindly for HIV-1 antibody by IF in each laboratory.
EIA. EIA screening for HIV-1 antibody was performed with the Abbott HTLV-III EIA kit (Abbott Laboratories, North Chicago, Ill.) according to the instructions of the manufacturer.
WB. We used the recommended Centers for Disease Control procedure for WB as described by Tsang et al. (32) , and the test was performed at one center, the Provincial Public Health Laboratory. At this laboratory, WB can detect an HIV-1-positive serum diluted 1:10-6 and will normally show up to 10 discrete bands. Purified HIV-1 was purchased from Organon Teknika, and 180 ,ug of protein was electrophoresed in a 12% polyacrylamide gel (2-mm thickness by 15 cm) by using a modified comb which makes one continuous well the full width of the gel plus a second well at one edge of the gel for molecular weight markers. Proteins were transferred to nitrocellulose, and the paper was cut into 3-mm strips. Sera were tested at a single dilution of 1:100, and anti-HIV-1 antibody was detected with biotin-conjugated goat anti-human immunoglobulin, horseradish peroxidase-labeled avidin D (Dupont-Biotech Research Laborato- (Table 1) . A total of 38 positives were in agreement. The 38 positives were made up of 23 original specimens and 15 specimens put in as blinded duplicate repeats, along with 5 true-negative repeats. Both laboratories identified these 38 positives correctly, yielding 100% repeatability. All five discordant serum specimens were repeatedly positive by EIA but negative by WB and were from blood donors. One was read as falsely positive by laboratory A, and four were read as falsely positive by laboratory B. All five were scored negative in both laboratories when they were repeated. Table 2 shows the sources of the sera and the HIV-1 antibody results for the 76 blood donors, 21 AIDS-ARC patients, 3 hemophiliacs, 7 multiply transfused patients, and Of special interest were eight serum specimens (five blood donors, two AIDS-ARC patients, and one hemophiliac) which were repeat EIA positive and WB indeterminate, having only anti-p24 or anti-gp4l bands (Table 3) . Both laboratories agreed on the IF results for al eight serum specimens; six were negative and two were positive. Both IF-positive sera were from AIDS patients, while the IFnegative sera were from five blood donors and one hemophiliac. Longitudinal follow-up of HIV-1-infected individuals has revealed that anti-p24 antibody may be the first antibody detectable by WB early after infection (2, 9, 12, 26, 31) and that anti-p24 antibody may be lost from serum late in the course of infection (5, 15) . Two serum specimens from AIDS patients, which normally show 10 bands by WB, showed only anti-gp4l antibody discretely. These sera were clearly positive by IF (8) .
DISCUSSION
Recently, rapid agglutination tests for the detection of HIV-1 antibody have appeared, including a latex agglutination test which uses recombinant envelope polypeptidecoated latex beads and a PPA test which uses detergentdisrupted virion antigen-coated gelatin particles (19, 21, 35 
